If you believe what medical technology executives are saying at the annual Advanced Medical Technology Association conference in Minneapolis, the device industry wants to change the agency driving reimbursement decisions: the Centers for Medicare & Medicaid Services.
The Food and Drug Administration, which ensures a device’s safety and efficacy before it’s allowed on the U.S. market, traditionally served as the device industry’s boogeyman. Industry executives have long called for shorter FDA review times for products and more transparent and predictable decisions from the agency.
